These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22405651)

  • 21. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
    Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H
    J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
    Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
    Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase.
    Grim JE; Gustafson MP; Hirata RK; Hagar AC; Swanger J; Welcker M; Hwang HC; Ericsson J; Russell DW; Clurman BE
    J Cell Biol; 2008 Jun; 181(6):913-20. PubMed ID: 18559665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
    Guo Z; Zhou Y; Evers BM; Wang Q
    Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.
    Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P
    Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.
    Lerner M; Lundgren J; Akhoondi S; Jahn A; Ng HF; Akbari Moqadam F; Oude Vrielink JA; Agami R; Den Boer ML; Grandér D; Sangfelt O
    Cell Cycle; 2011 Jul; 10(13):2172-83. PubMed ID: 21597324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity.
    Ponyeam W; Hagen T
    Cell Signal; 2012 Jan; 24(1):290-5. PubMed ID: 21946088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.
    Trausch-Azar JS; Abed M; Orian A; Schwartz AL
    J Cell Physiol; 2015 Apr; 230(4):842-52. PubMed ID: 25204433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
    Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
    Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
    Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
    Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ehrlichia chaffeensis TRP120-mediated ubiquitination and proteasomal degradation of tumor suppressor FBW7 increases oncoprotein stability and promotes infection.
    Wang JY; Zhu B; Patterson LL; Rogan MR; Kibler CE; McBride JW
    PLoS Pathog; 2020 Apr; 16(4):e1008541. PubMed ID: 32353058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.
    Xie CM; Wei W; Sun Y
    J Genet Genomics; 2013 Mar; 40(3):97-106. PubMed ID: 23522382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The
    Bagchi R; Melnyk CW; Christ G; Winkler M; Kirchsteiner K; Salehin M; Mergner J; Niemeyer M; Schwechheimer C; Calderón Villalobos LIA; Estelle M
    EMBO J; 2018 Jan; 37(2):255-268. PubMed ID: 29233834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7.
    Thompson BJ; Jankovic V; Gao J; Buonamici S; Vest A; Lee JM; Zavadil J; Nimer SD; Aifantis I
    J Exp Med; 2008 Jun; 205(6):1395-408. PubMed ID: 18474632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A C-terminal fragment of Cyclin E, generated by caspase-mediated cleavage, is degraded in the absence of a recognizable phosphodegron.
    Plesca D; Mazumder S; Gama V; Matsuyama S; Almasan A
    J Biol Chem; 2008 Nov; 283(45):30796-803. PubMed ID: 18784078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.
    Suryo Rahmanto A; Savov V; Brunner A; Bolin S; Weishaupt H; Malyukova A; Rosén G; Čančer M; Hutter S; Sundström A; Kawauchi D; Jones DT; Spruck C; Taylor MD; Cho YJ; Pfister SM; Kool M; Korshunov A; Swartling FJ; Sangfelt O
    EMBO J; 2016 Oct; 35(20):2192-2212. PubMed ID: 27625374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant regulation of FBW7 in cancer.
    Wang L; Ye X; Liu Y; Wei W; Wang Z
    Oncotarget; 2014 Apr; 5(8):2000-15. PubMed ID: 24899581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor.
    Fuchs SY
    Cancer Biol Ther; 2005 May; 4(5):506-8. PubMed ID: 15908780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological Functions of FBW7 in Metabolism.
    Zhang J; Kong DH; Huang X; Yu R; Yang Y
    Horm Metab Res; 2022 May; 54(5):280-287. PubMed ID: 35533672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.
    Thompson BJ; Buonamici S; Sulis ML; Palomero T; Vilimas T; Basso G; Ferrando A; Aifantis I
    J Exp Med; 2007 Aug; 204(8):1825-35. PubMed ID: 17646408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.